Cormorant Asset Management as of March 31, 2025
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 42 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 25.0 | $332M | 8.5M | 39.07 | |
| Edgewise Therapeutics (EWTX) | 6.8 | $90M | 4.1M | 22.00 | |
| Bridgebio Pharma (BBIO) | 5.2 | $69M | 2.0M | 34.57 | |
| Arcellx Common Stock (ACLX) | 5.2 | $69M | 1.1M | 65.60 | |
| Praxis Precision Medicines I Com New (PRAX) | 5.0 | $66M | 1.7M | 37.87 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 4.7 | $63M | 3.1M | 20.47 | |
| Janux Therapeutics (JANX) | 4.4 | $58M | 2.2M | 27.00 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 3.4 | $45M | 8.3M | 5.42 | |
| Insmed Com Par $.01 (INSM) | 3.0 | $40M | 525k | 76.29 | |
| Bright Minds Biosciences Com New (DRUG) | 2.9 | $38M | 1.1M | 36.07 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 2.5 | $33M | 2.9M | 11.30 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.4 | $33M | 2.3M | 14.38 | |
| Merus N V (MRUS) | 2.3 | $31M | 740k | 42.09 | |
| Rapport Therapeutics (RAPP) | 2.2 | $30M | 2.9M | 10.03 | |
| Axsome Therapeutics (AXSM) | 2.2 | $29M | 250k | 116.63 | |
| Pharvaris N V (PHVS) | 1.7 | $23M | 1.5M | 15.70 | |
| Gh Research Ordinary Shares (GHRS) | 1.7 | $22M | 2.0M | 11.03 | |
| Arcutis Biotherapeutics (ARQT) | 1.6 | $21M | 1.4M | 15.64 | |
| Tarsus Pharmaceuticals (TARS) | 1.5 | $21M | 400k | 51.37 | |
| Silverback Therapeutics (SPRY) | 1.5 | $20M | 1.6M | 12.58 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $20M | 600k | 33.54 | |
| Cg Oncology (CGON) | 1.4 | $19M | 775k | 24.49 | |
| Cargo Therapeutics (CRGX) | 1.0 | $14M | 3.4M | 4.07 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.0 | $13M | 2.1M | 6.25 | |
| Alumis (ALMS) | 1.0 | $13M | 2.1M | 6.14 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.9 | $13M | 2.4M | 5.31 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $12M | 400k | 29.52 | |
| Mestera (MTSR) | 0.8 | $11M | 400k | 27.22 | |
| Engene Holdings (ENGN) | 0.8 | $10M | 2.3M | 4.48 | |
| Bioage Labs (BIOA) | 0.7 | $9.9M | 2.6M | 3.76 | |
| Rhythm Pharmaceuticals (RYTM) | 0.6 | $7.9M | 150k | 52.97 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.6 | $7.9M | 1.8M | 4.30 | |
| Biomea Fusion (BMEA) | 0.6 | $7.6M | 3.6M | 2.13 | |
| Korro Bio (KRRO) | 0.5 | $6.6M | 380k | 17.41 | |
| Vaxcyte (PCVX) | 0.5 | $6.6M | 175k | 37.76 | |
| Aardvark Therapeutics (AARD) | 0.5 | $6.0M | 800k | 7.51 | |
| Mbx Biosciences (MBX) | 0.4 | $5.2M | 700k | 7.38 | |
| Enliven Therapeutics (ELVN) | 0.4 | $4.9M | 250k | 19.68 | |
| Pliant Therapeutics (PLRX) | 0.3 | $4.1M | 3.0M | 1.35 | |
| Kala Bio Com New (KALA) | 0.3 | $3.5M | 603k | 5.73 | |
| Stoke Therapeutics (STOK) | 0.1 | $1.7M | 254k | 6.65 | |
| Biohaven (BHVN) | 0.0 | $240k | 10k | 24.04 |
